A COMPARISON OF CLINICAL AND LABORATORY CHARACTERISTICS IN CIRRHOTIC PATIENTS WITH BLEEDING FROM GASTRIC VERSUS ESOPHAGEAL VARICES
Main Article Content
Abstract
Objective: To compare the clinical, laboratory characteristics, and severity of liver disease between two groups of cirrhotic patients hospitalized for upper gastrointestinal bleeding due to gastric versus esophageal variceal rupture. Methods: A cross-sectional, comparative, retrospective study was conducted on 150 cirrhotic patients with variceal bleeding, divided into two groups: the GV group (n=38) and the EV group (n=112), treated at Cho Ray Hospital from January 2024 to December 2024. T-test, Mann-Whitney U test, and Chi-square test were used for comparison. Results: Compared to the EV group, the GV group had a higher rate of hematemesis (82% vs. 46%; p < 0.001), a significantly higher rate of hemodynamic instability at admission (21% vs. 3%; p < 0.001), and a lower mean hemoglobin (Hb) level (74.7 g/L vs. 85.2 g/L; p = 0.046). There were no statistically significant differences in age, gender, etiology of cirrhosis, comorbidities, or mean Child-Pugh score between the two groups. Conclusion: The GV bleeding group presents with a more severe initial presentation and more massive blood loss. These results may help early etiologic orientation and risk stratification.
Article Details
Keywords
gastric varices, esophageal varices, liver cirrhosis, gastrointestinal hemorrhage.
References
2. Lesmana CRA, Shukla A, Kumar A, et al. Management of acute variceal bleeding: updated APASL guidelines. Hepatol Int. 2025. doi:10.1007/s12072-025-10894-4
3. Liu Y, Zhao S, Wang H, et al. Clinical characteristics and outcomes of esophageal versus gastric variceal bleeding in cirrhotic patients: a retrospective study. Hepatol Int. 2021;15(4):1072-1080. doi:10.1007/s12072-021-10200-9
4. Karakas E, Sahin TT, Aydin C. Comparison of Gastric and Esophageal Variceal Bleeding in Cirrhotic Patients. J Acta Medica. 2023;54(1):57-62.
5. Sharma M., Rameshbabu C. S. Collateral pathways in portal hypertension. Journal of clinical and experimental hepatology. Dec 2012;2(4):338-52. doi:10.1016/j.jceh.2012.08.001